COMMUNIQUÉS West-GlobeNewswire

Denali Therapeutics Announces Pricing of Initial Public Offering
08/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ) today announced the pricing of its initial public offering of 13,888,888 shares of its common stock at a price to [...]
Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast Cancer at the 2017 San Antonio Breast Cancer Symposium
08/12/2017
-Elacestrant 400mg single agent Objective Response Rate (ORR) was 27.3% in heavily pre-treated patients with advanced ER+ breast cancer at the pre-determined study cutoff date of October 30, 2017- -Median PFS was 5.4 [...]
MediciNova Announces Positive Top-Line Results from the Clinical Trial of MN-166 (ibudilast) in ALS
08/12/2017
LA JOLLA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Mesoblast Named Global Technology Leader in Cell Therapy Industry
07/12/2017
NEW YORK and MELBOURNE, Australia, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. [...]
Skyline Medical Issues Letter to Shareholders
07/12/2017
MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Gilead Sciences to Acquire Cell Design Labs
07/12/2017
– Demonstrates Gilead’s Deep Commitment to Cell Therapy – – Novel Cell Engineering Technologies with the Potential to Drive Discovery and Development of New Anti-Cancer Medicines – – Structured Buy Out to Acquire Cell [...]
National Research Corporation Declares Quarterly Dividend
07/12/2017
Lincoln, Nebraska, Dec. 07, 2017 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRCIA and NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (ten cents) per [...]
Flexion Therapeutics Enrolls First Patient in Phase 2 Pharmacokinetics and Safety Study of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension) in Bilateral Osteoarthritis of the Knee
07/12/2017
BURLINGTON, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) announced today the enrollment of the first patient in a clinical trial to evaluate the pharmacokinetics (PK) and safety of [...]
The Cooper Companies Announces Fourth Quarter and Full Year 2017 Results
07/12/2017
PLEASANTON, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced financial results for the fiscal fourth quarter and full year ended October 31, 2017. Fourth quarter revenue [...]
Intercept to Present at Upcoming Conference
07/12/2017
NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock
07/12/2017
TUSTIN, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) (Nasdaq: PPHMP ) today announced that its Board of Directors has declared a quarterly cash dividend payment on the [...]
Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
07/12/2017
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller [...]
Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference
07/12/2017
AUSTIN, Texas, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer
07/12/2017
SAN ANTONIO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that tucatinib in combination with standard of care agents [...]
Fennec Announces Proposed Public Offering of Common Shares
07/12/2017
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK™ (a unique formulation of sodium [...]
CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials
07/12/2017
COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full- [...]
BioInformatics LLC Expands Analyst Team and Customer Outreach
07/12/2017
ARLINGTON, Va., Dec. 07, 2017 (GLOBE NEWSWIRE) -- BioInformatics LLC announced a significant expansion of its Strategic Directions International (SDi) division to enhance the range of market research products and [...]
Tempus Unveils Tempus O, a Platform to Structure and Annotate Clinical Data at Scale
07/12/2017
CHICAGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data today announced the [...]
Annual General Meeting in Coloplast A/S - Election of own Chairman and Deputy Chairman
07/12/2017
See enclosed pdf.

Pages